Role of oxidative stress in cardiac hypertrophy and remodeling.
暂无分享,去创建一个
[1] D. Kass,et al. Peroxynitrite and myocardial contractility: in vivo versus in vitro effects. , 2006, Free radical biology & medicine.
[2] H. Tsutsui,et al. Mitochondrial oxidative stress, DNA damage, and heart failure. , 2006, Antioxidants & redox signaling.
[3] Min Zhang,et al. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. , 2006, Cardiovascular research.
[4] A. Zima,et al. Redox regulation of cardiac calcium channels and transporters. , 2006, Cardiovascular research.
[5] D. Kwiatkowski,et al. Requirement of Rac1 in the development of cardiac hypertrophy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] K. Sunagawa,et al. Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice , 2006, Circulation.
[7] A. Shah,et al. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. , 2006, Journal of the American College of Cardiology.
[8] R. Saraiva,et al. Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy , 2006, Circulation research.
[9] Marc A Pfeffer,et al. Controversies in ventricular remodelling , 2006, The Lancet.
[10] T. Münzel,et al. Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[11] R. Saraiva,et al. Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction: Role of Nitroso-Redox Equilibrium , 2005, Circulation.
[12] K. Rockett,et al. Stoichiometric Relationships Between Endothelial Tetrahydrobiopterin, Endothelial NO Synthase (eNOS) Activity, and eNOS Coupling in Vivo: Insights From Transgenic Mice With Endothelial-Targeted GTP Cyclohydrolase 1 and eNOS Overexpression , 2005, Circulation research.
[13] W. Leary,et al. Allopurinol or Oxypurinol in Heart Failure Therapy – a Promising New Development or End of Story? , 2005, Cardiovascular Drugs and Therapy.
[14] J. Duncan,et al. Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy. , 2005, American journal of physiology. Heart and circulatory physiology.
[15] R. Wessely,et al. Aortic Coarctation Visualized by 16-Row Detector Multislice Computed Tomography , 2005 .
[16] J. Loscalzo,et al. ATVB In Focus Redox Mechanisms in Blood Vessels , 2005 .
[17] K. Nakao,et al. Calcineurin–Nuclear Factor of Activated T Cells Pathway–Dependent Cardiac Remodeling in Mice Deficient in Guanylyl Cyclase A, a Receptor for Atrial and Brain Natriuretic Peptides , 2005, Circulation.
[18] C. Szabó,et al. Nitrosative stress and pharmacological modulation of heart failure. , 2005, Trends in pharmacological sciences.
[19] D. Kass,et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. , 2005, The Journal of clinical investigation.
[20] S. Yusuf,et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.
[21] R. Liao,et al. &agr;-Adrenergic Receptor–Stimulated Hypertrophy in Adult Rat Ventricular Myocytes Is Mediated via Thioredoxin-1–Sensitive Oxidative Modification of Thiols on Ras , 2005, Circulation.
[22] J. Stamler,et al. NO/redox disequilibrium in the failing heart and cardiovascular system. , 2005, The Journal of clinical investigation.
[23] Frank J Giordano,et al. Oxygen, oxidative stress, hypoxia, and heart failure. , 2005, The Journal of clinical investigation.
[24] J. Keaney,et al. Cytokine-Stimulated GTP Cyclohydrolase I Expression in Endothelial Cells Requires Coordinated Activation of Nuclear Factor-&kgr;B and Stat1/Stat3 , 2005, Circulation research.
[25] D. Kass,et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.
[26] Simon J. Walker,et al. A Nox2-containing NADPH oxidase contributes to cardiac remodeling after myocardial infarction , 2005 .
[27] E. Marbán,et al. Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy , 2004, Circulation research.
[28] J. Hare. Nitroso-redox balance in the cardiovascular system. , 2004, The New England journal of medicine.
[29] J. Hare,et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Shah,et al. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[31] D. Pimentel,et al. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide , 2004, Nature Medicine.
[32] H. Drexler,et al. Allopurinol Attenuates Left Ventricular Remodeling and Dysfunction After Experimental Myocardial Infarction: A New Action for an Old Drug? , 2004, Circulation.
[33] J. Fukuto,et al. Inhibition of the yeast metal reductase heme protein fre1 by nitric oxide (NO): a model for inhibition of NADPH oxidase by NO. , 2004, Free radical biology & medicine.
[34] R. Ferrari,et al. Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[35] N. Blau,et al. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. , 2004, Molecular genetics and metabolism.
[36] Masahiro Ito,et al. Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox , 2004, Circulation.
[37] J. Lambeth. NOX enzymes and the biology of reactive oxygen , 2004, Nature Reviews Immunology.
[38] N. Alp,et al. Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[39] A. Takeshita,et al. Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice , 2004, Circulation.
[40] W. Colucci,et al. Regulation of Matrix Metalloproteinases by Cytokines and Reactive Oxygen/Nitrogen Species in the Myocardium , 2004, Heart Failure Reviews.
[41] M. Hori,et al. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Sabri,et al. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. , 2003, Antioxidants & redox signaling.
[43] Don P Giddens,et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. , 2003, American journal of physiology. Heart and circulatory physiology.
[44] E. Olson,et al. Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.
[45] H. Yamawaki,et al. Thioredoxin: A Key Regulator of Cardiovascular Homeostasis , 2003, Circulation research.
[46] T. Cheng,et al. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. , 2003, Journal of the American College of Cardiology.
[47] F. Hofmann,et al. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. , 2003, Circulation research.
[48] Jing Liu,et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. , 2003, The Journal of clinical investigation.
[49] A. Shah,et al. Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy , 2003, Circulation research.
[50] U. Laufs,et al. Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment , 2003, Circulation.
[51] D. Harrison,et al. Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols , 2003, Journal of Biological Chemistry.
[52] A. Shah,et al. Increased myocardial NADPH oxidase activity in human heart failure. , 2003, Journal of the American College of Cardiology.
[53] D. Sawyer,et al. H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. , 2003, Journal of molecular and cellular cardiology.
[54] Michael D. Schneider,et al. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. , 2003, The Journal of clinical investigation.
[55] Steven M Holland,et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. , 2003, The Journal of clinical investigation.
[56] A. Shah,et al. Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II , 2003, The Journal of Biological Chemistry.
[57] C. Chiueh,et al. Cyclic GMP-dependent Protein Kinase Regulates the Expression of Thioredoxin and Thioredoxin Peroxidase-1 during Hormesis in Response to Oxidative Stress-induced Apoptosis* , 2003, The Journal of Biological Chemistry.
[58] J. Salerno,et al. Nitric oxide synthases: domain structure and alignment in enzyme function and control. , 2003, Frontiers in bioscience : a journal and virtual library.
[59] F. Spinale. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. , 2002, Circulation research.
[60] F. Murad,et al. Protein Nitration in Cardiovascular Diseases , 2002, Pharmacological Reviews.
[61] G. Fiskum,et al. The Role of Tetrahydrobiopterin in the Regulation of Neuronal Nitric-oxide Synthase-generated Superoxide* , 2002, The Journal of Biological Chemistry.
[62] A. Shah,et al. Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure , 2002, Hypertension.
[63] H. Drexler,et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[64] J. Cristol,et al. Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative Stress , 2002, Hypertension.
[65] Tomoya Yamashita,et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. , 2002, The Journal of clinical investigation.
[66] D. Sorescu,et al. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. , 2002, Congestive heart failure.
[67] K. Channon,et al. Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase , 2002, Circulation.
[68] D. Sawyer,et al. Role of oxidative stress in myocardial hypertrophy and failure. , 2002, Journal of molecular and cellular cardiology.
[69] D. Sawyer,et al. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. , 2002, American journal of physiology. Cell physiology.
[70] R. Cohen,et al. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. , 2002, The Journal of clinical investigation.
[71] M. Hori,et al. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. , 2002, Journal of the American College of Cardiology.
[72] B. Bozkurt,et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. , 2002, Cardiovascular research.
[73] Qin M. Chen,et al. Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. , 2002, The Journal of pharmacology and experimental therapeutics.
[74] D. Kass,et al. Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart , 2002, Circulation research.
[75] A. Shah,et al. Essential Role of the NADPH Oxidase Subunit p47phox in Endothelial Cell Superoxide Production in Response to Phorbol Ester and Tumor Necrosis Factor-&agr; , 2002, Circulation research.
[76] Yasushi Matsumura,et al. Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.
[77] A. Shah,et al. Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice , 2002, Circulation.
[78] C. Trautwein,et al. Gene Transfer of cGMP-Dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes , 2002, Hypertension.
[79] D. Sawyer,et al. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. , 2002, American journal of physiology. Cell physiology.
[80] Y. Zou,et al. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. , 2001, Biochemical and biophysical research communications.
[81] A. Takeshita,et al. 8-Oxo-dGTPase, Which Prevents Oxidative Stress-Induced DNA Damage, Increases in the Mitochondria From Failing Hearts , 2001, Circulation.
[82] Elias S. J. Arnér,et al. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.
[83] J. Ross,et al. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. , 2001, The Journal of clinical investigation.
[84] K. Node,et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. , 2001, The Journal of clinical investigation.
[85] D. Kass,et al. Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy , 2001, Circulation.
[86] L. Dell’Italia,et al. Differential MAP kinase activation and Na(+)/H(+) exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes. , 2001, American journal of physiology. Cell physiology.
[87] P. Anversa,et al. Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy , 2001, Circulation research.
[88] J. Knowles,et al. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. , 2001, The Journal of clinical investigation.
[89] D. Sawyer,et al. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. , 2001, Journal of molecular and cellular cardiology.
[90] D. Kang,et al. Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction , 2001, Circulation research.
[91] D. Garbers,et al. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[92] W. Little,et al. Allopurinol Enhances the Contractile Response to Dobutamine and Exercise in Dogs With Pacing-Induced Heart Failure , 2001, Circulation.
[93] Koichi Tanaka,et al. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. , 2001, Journal of the American College of Cardiology.
[94] D. Sawyer,et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. , 2001, Journal of molecular and cellular cardiology.
[95] P. Tsao,et al. Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase , 2001, Journal of cellular biochemistry. Supplement.
[96] W. Colucci,et al. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. , 2001, American journal of physiology. Cell physiology.
[97] C. Cooper,et al. Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.
[98] P. Bernocchi,et al. Enhanced expression and activity of xanthine oxidoreductase in the failing heart. , 2001, Journal of molecular and cellular cardiology.
[99] D. Kass,et al. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. , 2000, American journal of physiology. Heart and circulatory physiology.
[100] D. Sorescu,et al. NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.
[101] O. Hess,et al. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. , 2000, Journal of cardiovascular pharmacology.
[102] S. Yusuf,et al. Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.
[103] T. Horio,et al. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. , 2000, Hypertension.
[104] D. Kass,et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. , 1999, Circulation research.
[105] R. Busse,et al. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. , 1999, Circulation.
[106] S. Ball,et al. Modulation of recombinant human cardiac L‐type Ca2+ channel α1C subunits by redox agents and hypoxia , 1999, The Journal of physiology.
[107] J. Zweier,et al. Superoxide Generation from Endothelial Nitric-oxide Synthase , 1998, The Journal of Biological Chemistry.
[108] K. Mihara,et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. , 1998, Circulation.
[109] A. Samarel,et al. Hydrogen peroxide activates mitogen-activated protein kinases and Na+-H+ exchange in neonatal rat cardiac myocytes. , 1998, Circulation research.
[110] A. Omran,et al. Increased oxidative stress in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.
[111] D. Chatel,et al. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. , 1998, Circulation.
[112] E. Okabe,et al. Superoxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum through ryanodine receptor Ca2+ channel. , 1998, Molecular pharmacology.
[113] T. Lüscher,et al. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. , 1997, Circulation.
[114] L. Becker,et al. Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. , 1997, Circulation research.
[115] P. Hassoun,et al. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. , 1996, The American journal of physiology.
[116] P. Singal,et al. Role of oxidative stress in transition of hypertrophy to heart failure. , 1996, Journal of the American College of Cardiology.
[117] S. Snyder,et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[118] J. Manson,et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.
[119] ThomasHeitzer,et al. Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia , 1996 .
[120] M. Olschewski,et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. , 1996, Circulation.
[121] P. Hassoun,et al. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. , 1995, The American journal of physiology.
[122] M. Hori,et al. Ebselen protects against ischemia-reperfusion injury in a canine model of myocardial infarction. , 1994, The American journal of physiology.
[123] J. McMurray,et al. Evidence of oxidative stress in chronic heart failure in humans. , 1993, European heart journal.
[124] S. Abramson,et al. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. , 1992, The Journal of clinical investigation.